• Mashup Score: 0

    DESTIN, Fla. — Low disease activity and remission are achievable for patients with lupus if clinicians “minimize the prednisone” and administer adequate hydroxychloroquine, noted a speaker at the 2023 Congress of Clinical Rheumatology-East.

    Tweet Tweets with this article
    • “We are not using enough #HydroxyChloroquine [for #lupus],” Dr. Michelle Petri @jhrheumatology told #CCREast attendees. “Don’t be afraid to use our medications; if you don’t use it in a real dose, the patient cannot benefit from it.” #RheumTwiter https://t.co/LS1tqTCvbt https://t.co/tFSBlnzUkp